South Africa will introduce a groundbreaking twice-yearly HIV prevention injection, lenacapavir, in select public clinics by April 2026. This move marks a significant step forward in the nation’s fight against HIV, offering a highly effective and convenient alternative to daily pills. However, this progress comes as another long-acting injectable, cabotegravir (CAB-LA), remains stalled despite having a four-year head start. The…